WALTHAM, Mass.--(BUSINESS WIRE)--The Juvenile Diabetes Research Foundation (JDRF), the worldwide leader for research to cure, treat and prevent type 1 diabetes, and InnoCentive, Inc., the pioneer in open innovation and crowdsourcing, today announced a $100,000 Challenge calling for innovative ways to approach the discovery and development of a glucose-responsive insulin drug as a means to treat insulin-dependent diabetes. The Challenge is open to the public and can be found on the InnoCentive website at https://www.innocentive.com/ar/challenge/9932818.
